Crossmark

Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation

Crossref DOI link: https://doi.org/10.1016/j.jacc.2016.06.062

Published Print: 2016-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chan, Yi-Hsin

Kuo, Chi-Tai

Yeh, Yung-Hsin

Chang, Shang-Hung

Wu, Lung-Sheng

Lee, Hsin-Fu

Tu, Hui-Tzu

See, Lai-Chu
License Information

Text and Data Mining valid from 2016-09-01
More Information

This article is maintained by: Elsevier

Article Title: Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation

Journal Title: Journal of the American College of Cardiology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacc.2016.06.062

Content Type: article

Copyright: © 2016 by the American College of Cardiology Foundation. Published by Elsevier.